Implications of genetic testing for health policy.
ESSEC Business School, Paris-Singapore.
Gregory
G
Katz
Stuart O
SO
Schweitzer
D003132:Commerce; D003219:Confidentiality / Q000331:legislation & jurisprudence*; D017007:Duty to Warn / Q000331:legislation & jurisprudence; D005062:European Union; D005188:False Negative Reactions; D005189:False Positive Reactions; D035082:Federal Government; D005820:Genetic Testing / Q000331:legislation & jurisprudence* / Q000523:psychology / Q000592:standards; D017048:Health Care Costs / Q000331:legislation & jurisprudence; D006291:Health Policy / Q000331:legislation & jurisprudence*; D006801:Humans; D007348:Insurance, Health / Q000331:legislation & jurisprudence*; D008403:Mass Screening / Q000331:legislation & jurisprudence* / Q000523:psychology / Q000592:standards; D011287:Prejudice; D011295:Prenatal Care / Q000331:legislation & jurisprudence; D011296:Prenatal Diagnosis; D017149:Private Sector / Q000331:legislation & jurisprudence; D011785:Quality Assurance, Health Care; D012661:Semen; D012743:Sex Preselection; D013219:State Government; D013315:Stress, Psychological / Q000209:etiology; D014019:Tissue Donors / Q000331:legislation & jurisprudence; D006113:United Kingdom; D014481:United States; D015974:Wrongful Life